Physical Address
304 North Cardinal St.
Dorchester Center, MA 02124
Physical Address
304 North Cardinal St.
Dorchester Center, MA 02124

Pumpkin spice season looks a little different this year at Smoothie King. The chain just rolled out a smoothie made specifically for people taking GLP-1 medications like Ozempic, Wegovy, and Mounjaro. Smoothie King calls it the Slim-N-Trim GLP-1 Pumpkin Smoothie, and the chain says it’s the first pumpkin drink built with these patients in mind.
So what’s actually in it? The smoothie packs organic pumpkin puree, more than 23 grams of protein, and 9 grams of fiber. It skips added sugar entirely. That combination matters more than it might seem at first glance.
Here’s why. GLP-1 drugs slow digestion and curb appetite. That helps with weight loss, but it comes with a downside. People often eat less overall, which means they can end up short on protein too. Over time, that can trigger muscle loss, something doctors have flagged as a real concern with these medications.
High-protein foods help offset that risk. Building a smoothie around protein and fiber isn’t just a marketing angle. It actually addresses a gap that shows up a lot in patients managing obesity with these drugs.
This isn’t Smoothie King’s first move into GLP-1 territory, either. Back in October 2024, the chain launched what it called the first national quick-service menu built for GLP-1 users. A registered dietitian helped develop that original five-item lineup. Some of those smoothies contained up to 45 grams of protein.
Since then, GLP-1 prescriptions have exploded across the U.S. Smoothie King has clearly been paying attention to that trend, and this fall’s pumpkin lineup shows it. The chain now offers six pumpkin-flavored drinks, and each one targets a different nutritional need.
There’s the GLP-1 smoothie with 23 grams of protein. A high-protein coffee version follows, with 31 grams of protein and 83 milligrams of caffeine. There’s also a vegan option and a meal-replacement smoothie for people who want something more filling.
Company executives frame this as a natural extension of what they already do, not some new medical claim. Lori Primavera, the company’s VP of R&D and product marketing, said the goal is simply to apply Smoothie King’s nutrition know-how to a need that’s growing fast. Fair enough. But it’s worth remembering these are still just smoothies, not treatment.
If you’re on a GLP-1 medication, talk to your doctor before making major changes to your diet. Everyone tolerates these drugs differently, especially when it comes to digestion. What works for one person might not work for another.
There’s a bigger public health picture here too. The CDC has pointed to rising obesity-related health issues alongside the surge in GLP-1 prescribing. Meanwhile, CMS is still figuring out how, or whether, these medications should qualify for coverage under government health plans. That uncertainty, plus the cost of these drugs without insurance, shapes who can actually access and stick with treatment long-term.
Food chains jumping into this space isn’t really about medicine. It’s about brands adapting to a fast-growing group of customers navigating type 2 diabetes and weight management at once. Smoothie King’s pumpkin lineup runs through the end of September, and guests can find it at most of the chain’s nearly 1,200 U.S. locations, plus through its app.
One more thing worth noting: none of these products carry FDA health claims. Smoothie King markets them as food, not therapy, and that’s exactly how people should treat them.